# SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs

> **NCT06522048** · — · COMPLETED · sponsor: **Chao Ji** · enrollment: 300 (actual)

## Conditions studied

- Immune Checkpoint Inhibitor-Induced Dermatitis
- Stevens-Johnson Syndrome, Drug-Induced
- Toxic Epidermal Necrolysis Due to Drug

## Interventions

- **OTHER:** Observational studies do not require intervention

## Key facts

- **NCT ID:** NCT06522048
- **Lead sponsor:** Chao Ji
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2024-05
- **Final completion:** 2024-05
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2024-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06522048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06522048, "SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06522048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*